Trial intelligence / Profile preview

M-TAPA vs OSTAP for Postoperative Analgesia in Inguinal Hernia Repair

NCT05476510Completed

Sponsor
Istanbul Medipol University
Start
Aug 2022
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Postoperative pain scores (Numerical Rating Scale) at 24 hours. Started Aug 2022; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05476510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05476510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call